Selenium could reverse age-related memory lossSelenium could reverse age-related memory lossSelenium could reverse age-related memory lossSelenium could reverse age-related memory loss
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Robot

  • Home
  • News
  • Related Science News
  • Robot
February 11, 2022
February 11, 2022

Selenium could reverse age-related memory loss

Do you like it?
Read more
February 11, 2022
February 11, 2022

Versatile new pipeline enables study of gut bacteria

Do you like it?
Read more
February 11, 2022
February 11, 2022

Drug halts immune reactions to save damaged lungs

Do you like it?
Read more
February 10, 2022
February 10, 2022

Scientists discover new mechanism involved in learning and memory

Do you like it?
Read more
February 10, 2022
February 10, 2022

A protein present in the gum may help prevent Alzheimer’s

Do you like it?
Read more
February 10, 2022
February 10, 2022

Immune Cells Leave Fingerprints on Tumors Metastasized to the Brain Offering Clues to Future Therapies

Do you like it?
Read more
February 9, 2022
February 9, 2022

Scientists found genes, which could be linked to longevity in humans

Do you like it?
Read more
February 9, 2022
February 9, 2022

Genetically Informed Atlases Reveal New Landscapes in Brain Structure

Do you like it?
Read more
February 9, 2022
February 9, 2022

Researchers engineer human spinal cord implants for treating paralysis

Do you like it?
Read more
February 9, 2022
February 9, 2022

Cutting off liver cancer’s nutrient supply chain

Do you like it?
Read more
February 9, 2022
February 9, 2022

Exploring the architecture of tumours

Do you like it?
Read more
February 9, 2022
February 9, 2022

Risks after treatment for cervical neoplasia have declined over time

Do you like it?
Read more
February 9, 2022
February 9, 2022

Researchers discover repair properties of a protein critical for wound-healing in gut diseases

Do you like it?
Read more
February 9, 2022
February 9, 2022

Mental health is an issue for people with spinal cord injury. Chronic pain makes it worse

Do you like it?
Read more
February 9, 2022
February 9, 2022

Study suggests COVID-19 increases risk of pregnancy complications

Do you like it?
Read more
February 8, 2022
February 8, 2022

Advanced prostate cancer antibody drug shows success in pet dogs

Do you like it?
Read more
February 8, 2022
February 8, 2022

Glaucoma: seeing the light at the end of the (nano)tunnel

Do you like it?
Read more
February 8, 2022
February 8, 2022

This protein can shred our cells. Or it can help us think.

Do you like it?
Read more
February 8, 2022
February 8, 2022

Seizures Can Cause Memory Loss; Brain-Mapping Research Suggests One Reason Why

Do you like it?
Read more
February 8, 2022
February 8, 2022

Researcher takes another step toward virtual immune system

Do you like it?
Read more
February 8, 2022
February 8, 2022

Ally and enemy? Scientists explore immune cell suspect in Alzheimer’s

Do you like it?
Read more
February 8, 2022
February 8, 2022

Urgent need for radioactive substances for cancer treatment

Do you like it?
Read more
February 7, 2022
February 7, 2022

Sleep problems pervasive and persistent among children with epilepsy 

Do you like it?
Read more
February 7, 2022
February 7, 2022

Research could find new triggers of heart attacks and strokes

Do you like it?
Read more
February 7, 2022
February 7, 2022

Cervical samples could reveal risk of breast and ovarian cancer

Do you like it?
Read more
February 7, 2022
February 7, 2022

SARS-CoV-2 Spike protein binds to heart’s vascular cells potentially contributing to severe microvascular damage

Do you like it?
Read more
February 7, 2022
February 7, 2022

Widely-used hormone drug associated with increased risk of benign brain tumour at high doses

Do you like it?
Read more
February 7, 2022
February 7, 2022

A new methodology for network studies

Do you like it?
Read more
February 7, 2022
February 7, 2022

New computational tool predicts cell fates and genetic perturbations

Do you like it?
Read more
February 7, 2022
February 7, 2022

Discovery shows long-term viability of stem cell derived retinal implant

Do you like it?
Read more
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311
Next page
© 2017 - 2025 Innovita Research | Privacy policy